| 10-Q | 2021-03-31 | Filed 2021-05-14 |
| 10-K | 2020-12-31 | Filed 2021-03-19 |
| 10-Q | 2020-09-30 | Filed 2020-11-09 |
| 10-Q | 2020-06-30 | Filed 2020-08-10 |
| 10-Q | 2020-03-31 | Filed 2020-05-08 |
| 10-K | 2019-12-31 | Filed 2020-03-13 |
| 10-Q | 2019-09-30 | Filed 2019-11-12 |
| 10-Q | 2019-06-30 | Filed 2019-08-08 |
| 10-Q | 2019-03-31 | Filed 2019-05-09 |
| 10-K | 2018-12-31 | Filed 2019-03-15 |
| 10-Q | 2018-09-30 | Filed 2018-11-09 |
| 10-Q | 2018-06-30 | Filed 2018-08-09 |
| 10-Q | 2018-03-31 | Filed 2018-05-10 |
| 10-K | 2017-12-31 | Filed 2018-03-05 |
| 10-Q | 2017-09-30 | Filed 2017-11-09 |
| 10-Q | 2017-06-30 | Filed 2017-07-21 |
| 10-Q | 2017-03-31 | Filed 2017-05-10 |
| 10-K | 2016-12-31 | Filed 2017-02-23 |
| 10-Q | 2016-09-30 | Filed 2016-11-07 |
| 10-Q | 2016-06-30 | Filed 2016-08-09 |
| 10-Q | 2016-03-31 | Filed 2016-05-10 |
| 10-K | 2015-12-31 | Filed 2016-03-15 |
| 10-Q | 2015-09-30 | Filed 2015-11-12 |
| 10-Q | 2015-06-30 | Filed 2015-08-11 |
| 10-Q | 2015-03-31 | Filed 2015-05-08 |
| 10-K | 2014-12-31 | Filed 2015-03-03 |
| 10-Q | 2014-09-30 | Filed 2014-10-31 |
| 10-Q | 2014-06-30 | Filed 2014-08-13 |
| 10-Q | 2014-03-31 | Filed 2014-05-20 |
| 8-K | 2021-02-11 | Officers |
| 8-K | 2021-01-21 | Enter Agreement |
| 8-K | 2020-12-07 | Enter Agreement, Sale of Shares, Officers, Regulation FD, Exhibits |
| 8-K | 2020-11-10 | |
| 8-K | 2020-11-09 | |
| 8-K | 2020-10-29 | |
| 8-K | 2020-08-10 | |
| 8-K | 2020-05-28 | |
| 8-K | 2020-05-07 | |
| 8-K | 2020-03-12 | |
| 8-K | 2020-03-11 | |
| 8-K | 2019-11-11 | |
| 8-K | 2019-10-28 | |
| 8-K | 2019-08-06 | |
| 8-K | 2019-05-08 | |
| 8-K | 2019-05-03 | |
| 8-K | 2019-03-13 | |
| 8-K | 2019-02-06 | |
| 8-K | 2018-11-05 | |
| 8-K | 2018-10-01 | |
| 8-K | 2018-09-12 | |
| 8-K | 2018-08-08 | |
| 8-K | 2018-05-09 | |
| 8-K | 2018-05-02 | |
| 8-K | 2018-04-20 | |
| 8-K | 2018-04-10 | |
| 8-K | 2018-03-19 | |
| 8-K | 2018-03-09 | |
| 8-K | 2018-03-01 | |
| 8-K | 2018-01-18 |
| Comps ($MM TTM) | Market Cap | Gross Margin | EV/EBITDA | Ret on Assets | Assets | Liabilities | Revenue | G Profit | Net Income | EBITDA | EV |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 024 Pharma (EEIG) | |||||||||||
| 11 Good Energy (ELVN) | |||||||||||
| 1347 Capital Corp (TFSC) | |||||||||||
| Ameren Illinois Co (AILNP) | |||||||||||
| 1PM Industries (OPMZ) | |||||||||||
| 1st Century Bancshares (FCTY) | |||||||||||
| 1st Financial Services Corp (FFIS) | |||||||||||
| 1st United Bancorp (FUBC) | |||||||||||
| 2-Track Global (TTG) | |||||||||||
| ENTERGY ARKANSAS, LLC (EAI) | |||||||||||
| 21st Century Oncology Holdings (RTSX) | |||||||||||
| 24Holdings (TWFH) | |||||||||||
| Bioquest Corp (BQST) | |||||||||||
| 30DC (TDCH) | |||||||||||
| BriaCell Therapeutics Corp. (BCTXW) | |||||||||||
| DD3 Acquisition Corp. II (DDMXW) | |||||||||||
| 3D Total Solutions (DTLS) | |||||||||||
| 3DX Industries (DDDX) | |||||||||||
| 8i Acquisition 2 Corp. (LAX) | |||||||||||
| ALABAMA POWER CO (APRCP) |
| Balance Sheet ($MM) | 2014-06-30 | 2014-09-30 | 2014-12-31 | 2015-03-31 | 2015-06-30 | 2015-09-30 | 2015-12-31 | 2016-03-31 | 2016-06-30 | 2016-09-30 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
| Cash | 5 | 64 | 34 | 18 | 21 | 43 | 24 | 36 | 32 | 17 | 47 | 6 | 29 | 129 | 54 | 20 | 26 | 24 | 17 | 19 | 22 | 9 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 2 | 2 | 4 | 3 | 3 | 3 | 7 | 6 | 4 | 5 | 6 | 8 | 5 | 5 |
| Inventory | ||||||||||||||||||||||
| PP&E | 70 | 74 | 166 | 179 | 290 | 305 | 316 | 556 | 570 | 588 | 594 | 953 | 970 | 976 | 1,092 | 1,122 | 1,122 | 1,101 | 1,100 | 1,096 | 1,074 | 1,072 |
| Assets | 77 | 139 | 201 | 199 | 313 | 352 | 345 | 598 | 610 | 612 | 656 | 971 | 1,013 | 1,120 | 1,166 | 1,163 | 1,168 | 1,145 | 1,140 | 1,138 | 1,112 | 1,097 |
| Accounts Payable | ||||||||||||||||||||||
| Long-Term Debt | 31 | 51 | 114 | 108 | 184 | 190 | 187 | 290 | 298 | 303 | 310 | 438 | 487 | 466 | 516 | 516 | 536 | 525 | 525 | 523 | 514 | 513 |
| Liabilities | 35 | 55 | 117 | 116 | 197 | 203 | 197 | 308 | 313 | 316 | 320 | 464 | 508 | 481 | 530 | 541 | 555 | 537 | 536 | 546 | 531 | 526 |
| Stockholders' Equity | ||||||||||||||||||||||
| Income Statement ($MM) | 2014-06-30 | 2014-09-30 | 2014-12-31 | 2015-03-31 | 2015-06-30 | 2015-09-30 | 2015-12-31 | 2016-03-31 | 2016-06-30 | 2016-09-30 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
| Revenue | 11 | 11 | 13 | 21 | 11 | 11 | 10 | |||||||||||||||
| Cost of Revenue | ||||||||||||||||||||||
| Gross Profit | ||||||||||||||||||||||
| R&D | ||||||||||||||||||||||
| SG&A | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 1 | 2 | 2 | 2 | 1 | 1 | 1 | |
| Tax | 0 | 0 | 0 | -0 | 0 | -0 | ||||||||||||||||
| Net Income | -0 | 0 | -0 | -0 | 0 | 1 | 1 | -1 | 1 | 0 | 7 | -2 | 2 | 3 | 7 | 1 | 1 | 4 | 8 | 0 | 7 | -1 |
| Cash Flow ($MM) | 2014-06-30 | 2014-09-30 | 2014-12-31 | 2015-03-31 | 2015-06-30 | 2015-09-30 | 2015-12-31 | 2016-03-31 | 2016-06-30 | 2016-09-30 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
| Cash Operating | -1 | 0 | 5 | 5 | -1 | -1 | 6 | -1 | -1 | 1 | -3 | -2 | 4 | 15 | -1 | -0 | 14 | -2 | -5 | |||
| Cash Investing | -4 | -89 | -13 | -77 | -17 | -13 | -94 | -15 | -18 | -10 | -85 | -8 | -120 | -34 | -3 | 21 | 3 | 32 | -1 | |||
| Cash Financing | 63 | 59 | -7 | 75 | 40 | -5 | 100 | 13 | 4 | 39 | 46 | 110 | 40 | -15 | 10 | -23 | -14 | -27 | -8 | |||